A detailed history of Man Group PLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Man Group PLC holds 10,519 shares of MDXG stock, worth $78,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,519
Previous 22,487 53.22%
Holding current value
$78,576
Previous $173,000 58.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $73,722 - $96,701
-11,968 Reduced 53.22%
10,519 $72,000
Q1 2024

May 15, 2024

SELL
$7.61 - $8.63 $168,584 - $191,180
-22,153 Reduced 49.63%
22,487 $173,000
Q4 2023

Feb 14, 2024

SELL
$5.7 - $9.14 $201,814 - $323,610
-35,406 Reduced 44.23%
44,640 $391,000
Q3 2023

Nov 14, 2023

SELL
$6.35 - $8.16 $103,581 - $133,105
-16,312 Reduced 16.93%
80,046 $583,000
Q2 2023

Aug 14, 2023

SELL
$3.14 - $6.61 $3,271 - $6,887
-1,042 Reduced 1.07%
96,358 $636,000
Q1 2023

May 15, 2023

SELL
$2.97 - $4.81 $12,771 - $20,683
-4,300 Reduced 4.23%
97,400 $332,000
Q4 2022

Feb 14, 2023

BUY
$2.63 - $3.45 $107,041 - $140,415
40,700 Added 66.72%
101,700 $282,000
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $165,310 - $257,419
61,000 New
61,000 $175,000
Q1 2022

May 16, 2022

SELL
$4.27 - $6.27 $103,082 - $151,364
-24,141 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$5.7 - $8.48 $108,533 - $161,467
-19,041 Reduced 44.09%
24,141 $146,000
Q3 2021

Nov 15, 2021

BUY
$5.52 - $15.83 $238,364 - $683,571
43,182 New
43,182 $261,000
Q4 2018

Feb 14, 2019

SELL
$1.15 - $6.45 $55,856 - $313,282
-48,571 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $66,882 - $131,480
20,771 Added 74.72%
48,571 $300,000
Q2 2018

Aug 14, 2018

BUY
$5.39 - $8.96 $149,842 - $249,088
27,800 New
27,800 $178,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $849M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.